Rubin Eyal
Insider CIK 1721411 · PLX Sr. VP and CFO · BCLI CFO and Treasurer · NSRX Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PLX Protalix BioTherapeutics, | A Award | 2024-09-23 | 2024-11-05 | 90,909 | — | $0 | 660,909 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award | 2024-09-23 | 2024-09-24 | 99,010 | — | $0 | 669,010 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award | 2023-08-15 | 2023-08-17 | 201,903 | — | $0 | 570,000 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award deriv | 2022-09-07 | 2022-09-09 | 350,000 | — | $0 | 350,000 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award | 2022-02-25 | 2022-02-28 | 121,951 | — | $0 | 368,097 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award | 2020-08-11 | 2020-08-13 | 246,146 | — | $0 | 246,146 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award | 2020-08-11 | 2020-08-14 | 246,146 | — | $0 | 246,146 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award deriv | 2019-09-22 | 2019-09-24 | 800,000 | — | $0 | 800,000 | SEC↗ |
| BCLI BRAINSTORM CELL THERAPEUTI | A Award deriv | 2017-11-20 | 2017-11-20 | 93,686 | — | $0 | 93,686 | SEC↗ |
| BCLI BRAINSTORM CELL THERAPEUTI | A Award | 2017-11-20 | 2017-11-20 | 25,000 | — | $0 | 25,000 | SEC↗ |